Quality of life and outcome in stage IV non-small cells lung cancer patients : A prospective study.

Quality of life and outcome in stage IV lung cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202104725647601

Enrollment

100

Registered

2021-04-07

Start date

2018-02-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Vinorelbine plus platinum

Gemcitabine plus platinum

Docetaxel plus platinum

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Confirmed NSCLC with histological proof. Written informed consent

Exclusion criteria

Exclusion criteria: Other comorbidities associated to NSCLC which interfere with quality of life Anterior sleep disturbance known before lung cancer diagnosis Pharmacological treatment interfering with sleep quality Severe pain with intensity in visual analogical scale (VAS) greater than 6/10, leading to prescription of oral opioïd therapy

Design outcomes

Primary

Measure	Time frame
overall survival	—

Secondary

Measure	Time frame
response to chemotherapy;progression free survival	—

Countries

Tunisia

Contacts

Public Contactfatma chermiti ben abdallah

service de pneumologie Pavillon 4

cherabdallah@yahoo.fr+21670160300

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026